The Austrian Breast and Colorectal Cancer Study Group trial-12 (ABCSG-12) randomized, open-label, phase III study was designed to compare tamoxifen plus goserelin versus anastrozole plus goserelin ...
The study included premenopausal patients with stage I-III hormone receptor-positive breast cancer who had received leuprolide or goserelin in combination with either an aromatase inhibitor or ...